Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Asola M et al. |
Amino acid uptake in the skeletal muscle measured using (11C)methylaminoisobutyrate (MEAIB) and PET.
|
2 |
Ekholm E et al. |
Docetaxel does not impair cardiac autonomic function in breast cancer patients previously treated with anthracyclines.
|
3 |
El-Nezami H et al. |
Lactic acid bacteria and bifidobacteria can reduce dietary exposure to aflatoxins.
|
4 |
Erjala K et al. |
Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in vitro.
|
5 |
Glimelius B et al. |
Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer.
|
6 |
Hakanen AT et al. |
Dosimetry in the irradiation of thin culture layers using a 60Co radiotherapy unit at 20 cm SSD.
|
7 |
Hicks RJ et al. |
FDG PET: Revolution or evolution in the management of non-small cell lung cancer?
|
8 |
Holli K et al. |
Rintasyöpä.
|
9 |
Hujala K et al. |
Combined external and intraluminal radiotherapy in the treatment of advanced oesophageal cancer.
|
10 |
Ilmonen S et al. |
Prognosis of primary melanoma.
|
11 |
Johansson R et al. |
Ihomelanooma.
|
12 |
Johansson R et al. |
Ihon levyepiteeli- ja tyvisolusyöpä.
|
13 |
Kankuri M et al. |
Jaksotettu pitkäaikainen alfainterferonihoito on hyödyllinen metastasoituneessa munuaissyövässä.
|
14 |
Kellokumpu-Lehtinen P et al. |
Palliatiivinen sädehoito.
|
15 |
Kellokumpu-Lehtinen P et al. |
Paclitaxel-ifosfamide for anthracycline-resistant advanced breast cancer.
|
16 |
Koivusalo R et al. |
Chemoradiation of cervical cancer cells: Targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
|
17 |
Korpela J, Salminen E. |
Neutropenic infections add significant costs to palliative chemotherapy in breast cancer.
|
18 |
Korpela M et al. |
Pineaaliseudun syöpä.
|
19 |
Kouri M et al. |
Kallonsisäisten kohteiden stereotaktinen sädehoito.
|
20 |
Kouri M et al. |
Peräsuolisyöpä.
|
21 |
Kulmala J et al. |
Kokoihon elektronihoito.
|
22 |
Lindholm P et al. |
Kohdunrungon syöpä.
|
23 |
Lindholm P et al. |
Kohdunkaulan syöpä.
|
24 |
Luukkaa M et al. |
Neodymium YAG contact laser in the treatment of cancer of the mobile tongue.
|
25 |
Mali P. |
Pienisoluinen keuhkosyöpä.
|
26 |
Minn H et al. |
Anemia ja sädehoito.
|
27 |
Minn H et al. |
Aivolisäkkeen kasvaimet.
|
28 |
Minn H et al. |
Alanielun syöpä.
|
29 |
Muhonen A et al. |
Osteodistraction of a previously irradiated mandible with or without adjunctive hyperbaric oxygenation: An experimental study in rabbits.
|
30 |
Muhonen A et al. |
The effects of irradiation and hyberbaric oxygen on bone formation during rabbit mandibular distraction.
|
31 |
Mäenpää H et al. |
Glioomat.
|
32 |
Männistö S, Salminen E. |
Rintasyöpä - naisten yleisin syöpä.
|
33 |
Nikkanen V. |
Syöpälääkärin iloja ja suruja.
|
34 |
Nikkola J et al. |
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.
|
35 |
Ouwehand AC et al. |
Dependent adhesion of lactic acid bacteria to colonic tissue in vitro.
|
36 |
Ouwehand AC et al. |
Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria.
|
37 |
Paajanen H et al. |
Novel serum inflammatory markers in acute appendicitis.
|
38 |
Palmu S et al. |
Expression of C-KIT and HER-2 tyrosine kinase receptors in poor-prognosis breast cancer.
|
39 |
Powles T et al. |
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.
|
40 |
Pyrhönen S. |
Paksu- ja peräsuolisyövän liitännäishoito.
|
41 |
Raitanen M et al. |
Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines.
|
42 |
Rantanen V et al. |
Paclitaxel sensitivity of 27 gynecologic cancer cell lines.
|
43 |
Ristamäki R. |
Levinneen paksu- ja peräsuolisyövän hoito.
|
44 |
Salminen E. |
Suositukset ravinnosta ja liikunnasta syövän ehkäisyssä.
|
45 |
Salminen E. |
Vanhusten syövän hoito.
|
46 |
Salminen E. |
Ravintoon liittyvät kysymykset kiinnostavat syöpäpotilaita.
|
47 |
Salminen E. |
Rintasyövän solunsalpaajahoidon sydänhaittavaikutuksista.
|
48 |
Salminen E et al. |
Breast cancer patients have unmet needs for dietary advice.
|
49 |
Salminen E et al. |
Hyvänlaatuiset sairaudet.
|
50 |
Salminen E et al. |
Female patients tend to alter their diet following the diagnosis of rheumatoid arthritis and breast cancer.
|
51 |
Salminen E et al. |
Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice.
|
52 |
Salminen E et al. |
Epirubicin/docetaxel regimen in progressive breast cancer - a phase II study.
|
53 |
Salminen E, Mac Manus M. |
FDG-PET imaging in the management of non-small-cell lung cancer.
|
54 |
Salminen E, Nurmi M. |
Metastasizing renal cell cancer.
|
55 |
Salminen E, Pitkälä K. |
Vanhus syöpäpotilaana.
|
56 |
Tolvanen T et al. |
18F-fluoroerythronitroimidazole radiation dosimetry in cancer studies.
|
57 |
Utriainen M et al. |
Metabolic characterization of childhood brain tumors.
|
58 |
Valavaara R et al. |
Suuontelon syöpä.
|
59 |
Valavaara R et al. |
Suunielun syöpä.
|
60 |
Valavaara R et al. |
Lymfoomat.
|
61 |
Vihinen P, Kähäri V-M. |
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
|
62 |
Vihinen P, Kähäri V-M. |
Matrix metalloproteinases and their inhibitors in human melanoma.
|
63 |
Vlaykova T et al. |
Immunohistochemically detectable Bcl-2 expression in metastatic melanoma: Association with survival and treatment response.
|
64 |
Vlaykova T. |
Prognostic factors in metastatic melanoma: Special reference to tumor vascularity, proliferation and Bcl-2 expression.
|
65 |
Voutilainen L et al. |
Sylkirauhasen syöpä.
|